Pfizer Limited
NSE:PFIZER.NS
5286.85 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21,931.7 | 24,247.6 | 26,105.5 | 22,384.3 | 21,515.1 | 20,814.2 | 19,684.7 | 19,661.854 | 19,948.57 | 18,277.444 | 10,042.72 | 9,479.773 | 10,173.006 | 0 | 7,722.717 | 6,816.972 | 6,766.933 | 6,667.94 | 6,296.905 | 5,930.603 |
| Cost of Revenue
| 12,026.5 | 8,736.7 | 9,480.3 | 7,977.4 | 7,924 | 7,479 | 7,396.8 | 7,965.352 | 7,852.65 | 7,403.374 | 3,752.704 | 3,334.874 | 3,595.262 | 0 | 3,219.006 | 2,707.969 | 2,340.616 | 2,569.437 | 2,404.025 | 2,575.61 |
| Gross Profit
| 9,905.2 | 15,510.9 | 16,625.2 | 14,406.9 | 13,591.1 | 13,335.2 | 12,287.9 | 11,696.502 | 12,095.92 | 10,874.07 | 6,290.016 | 6,144.899 | 6,577.744 | 0 | 4,503.711 | 4,109.003 | 4,426.317 | 4,098.503 | 3,892.88 | 3,354.993 |
| Gross Profit Ratio
| 0.452 | 0.64 | 0.637 | 0.644 | 0.632 | 0.641 | 0.624 | 0.595 | 0.606 | 0.595 | 0.626 | 0.648 | 0.647 | 0 | 0.583 | 0.603 | 0.654 | 0.615 | 0.618 | 0.566 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 275.004 | 205.382 | 173.986 | 147.568 | 175.518 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 3,481.3 | 2,646.6 | 1,291.5 | 972.9 | 867.1 | 742.9 | 705.6 | 776.873 | 713.345 | 714.806 | 507.357 | 539.152 | 420.495 | 0 | 868.092 | 812.888 | 0 | 745.229 | 745.658 | 791.31 |
| Selling & Marketing Expenses
| 855.9 | 615.9 | 1,481.1 | 1,378.7 | 1,537 | 1,528.3 | 1,433.5 | 1,528.328 | 1,738.594 | 1,560.365 | 876.143 | 1,000.629 | 1,062.376 | 0 | 520.213 | 458.022 | 0 | 450.804 | 338.899 | 337.115 |
| SG&A
| 4,175 | 3,262.5 | 2,772.6 | 2,351.6 | 2,404.1 | 2,271.2 | 2,139.1 | 2,305.201 | 2,451.939 | 2,275.171 | 1,383.5 | 1,539.781 | 1,482.871 | 0 | 1,388.305 | 1,270.91 | 0 | 1,196.033 | 1,084.557 | 1,128.425 |
| Other Expenses
| 1,805.1 | 8,477.4 | 6,628.2 | 6,020.2 | 6,436.6 | 107.9 | 88.9 | 82.479 | 113.347 | 216.621 | 153.655 | 144.524 | 119.266 | 0 | -109.177 | 2,079.068 | 321.679 | -233.683 | -233.683 | -192.238 |
| Operating Expenses
| 4,175 | 8,477.4 | 9,400.8 | 8,371.8 | 8,840.7 | 8,368.3 | 7,940.5 | 8,824.518 | 8,915.841 | 8,333.245 | 3,906.992 | 4,333.927 | 4,462.597 | 0 | 2,294.433 | 1,996.797 | 321.679 | 2,237.655 | 2,622.208 | 2,484.425 |
| Operating Income
| 5,730.2 | 8,044 | 7,785.3 | 6,783.6 | 6,194.7 | 4,966.9 | 4,347.4 | 2,871.984 | 3,180.079 | 2,540.825 | 2,383.024 | 1,810.972 | 2,115.147 | 0 | 2,209.278 | 2,112.206 | 4,104.638 | 1,860.848 | 1,270.672 | 870.568 |
| Operating Income Ratio
| 0.261 | 0.332 | 0.298 | 0.303 | 0.288 | 0.239 | 0.221 | 0.146 | 0.159 | 0.139 | 0.237 | 0.191 | 0.208 | 0 | 0.286 | 0.31 | 0.607 | 0.279 | 0.202 | 0.147 |
| Total Other Income Expenses Net
| 1,730.5 | 196.1 | -56.4 | -96.4 | 230.2 | 1,632.2 | 1,131.7 | 2,296.405 | 842.036 | -160.666 | 1,012.826 | 5,126.68 | 660.142 | 0 | -109.177 | 2,079.068 | 408.806 | -234.398 | -152.068 | -125.508 |
| Income Before Tax
| 7,460.7 | 8,240.1 | 7,728.9 | 6,687.2 | 6,424.9 | 6,599.1 | 5,479.1 | 5,168.389 | 4,022.115 | 2,380.159 | 3,395.85 | 6,937.652 | 2,775.289 | 0 | 2,100.101 | 4,191.274 | 4,513.444 | 1,626.45 | 1,118.604 | 745.06 |
| Income Before Tax Ratio
| 0.34 | 0.34 | 0.296 | 0.299 | 0.299 | 0.317 | 0.278 | 0.263 | 0.202 | 0.13 | 0.338 | 0.732 | 0.273 | 0 | 0.272 | 0.615 | 0.667 | 0.244 | 0.178 | 0.126 |
| Income Tax Expense
| 1,947.4 | 2,000.8 | 1,603.3 | 1,711.1 | 1,333.6 | 2,308.6 | 1,878.4 | 1,800.553 | 1,794.382 | 1,376.765 | 1,187.279 | 1,905.674 | 929.227 | 0 | 731.268 | 1,195.551 | 1,113.418 | 563.103 | 411.275 | 299.184 |
| Net Income
| 5,513.3 | 6,239.3 | 6,125.6 | 4,976.1 | 5,091.3 | 4,290.5 | 3,600.7 | 3,367.836 | 2,227.733 | 698.193 | 2,208.571 | 5,031.978 | 1,694.429 | 0 | 1,368.833 | 2,995.723 | 3,400.026 | 1,063.347 | 707.329 | 445.876 |
| Net Income Ratio
| 0.251 | 0.257 | 0.235 | 0.222 | 0.237 | 0.206 | 0.183 | 0.171 | 0.112 | 0.038 | 0.22 | 0.531 | 0.167 | 0 | 0.177 | 0.439 | 0.502 | 0.159 | 0.112 | 0.075 |
| EPS
| 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.7 | 73.61 | 66.66 | 21.93 | 74.01 | 168.63 | 61.87 | 0 | 45.87 | 100.24 | 113.94 | 35.63 | 23.7 | 14.94 |
| EPS Diluted
| 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.7 | 73.61 | 66.66 | 21.93 | 74.01 | 168.63 | 61.87 | 0 | 45.87 | 100.24 | 113.94 | 35.63 | 23.7 | 14.94 |
| EBITDA
| 6,353 | 9,099.1 | 8,935.3 | 7,877.7 | 7,227.6 | 7,015.7 | 6,074.5 | 4,457.989 | 5,067.321 | 4,491.605 | 3,457.999 | 2,918.578 | 3,104.783 | 0 | 2,292.154 | 2,223.425 | 4,782.946 | 1,991.561 | 1,409.131 | 973.141 |
| EBITDA Ratio
| 0.29 | 0.375 | 0.342 | 0.352 | 0.336 | 0.337 | 0.309 | 0.227 | 0.254 | 0.246 | 0.344 | 0.308 | 0.305 | 0 | 0.297 | 0.326 | 0.707 | 0.299 | 0.224 | 0.164 |